logo
Select company
Select metric
$ 2.82MCapital Expenditure
VS
Market
62
Sector
32
Industry
15
History
87
$ 12.64Close
$ 5.31 - $ 12.64 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 2.82M
3/31/2025$ 2.9M
12/31/2024$ 2.44M
9/30/2024$ 2.48M
6/30/2024$ 3.6M
3/31/2024$ 5.7M
12/31/2023$ 9.96M
9/30/2023$ 14.3M
6/30/2023$ 17.91M
3/31/2023$ 24.57M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) CapEx stands at $ 15.01M.
  • Over the past 5 years, REGENXBIO INC's average CapEx has been $ 30.33M.
  • The median CapEx for REGENXBIO INC during this period was $ 21.25M
  • REGENXBIO INC reached its highest CapEx over the past 5 years at $ 84.17M.
  • The lowest CapEx recorded by REGENXBIO INC in the same timeframe $ 2.44M

REGENXBIO INC's CapEx vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Benchmarks
CompanyCapEx
CTMX : CYTOMX THERAPEUTICS INC $ 245KXNCR : XENCOR INC $ 4.77MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 217KYMAB : Y-MABS THERAPEUTICS INC $ 127KGLUE : MONTE ROSA THERAPEUTICS INC $ 3.86MHRTX : HERON THERAPEUTICS INC $ 1.31MNKTR : NEKTAR THERAPEUTICS $ -64.22MPACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC $ 2.77MLXRX : LEXICON PHARMACEUTICALS INC $ 781KVNDA : VANDA PHARMACEUTICALS INC $ 1.11M

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

RGNX - Capital Expenditure, Last 5 years

$ 2.44M

Minimum

Dec 31, 2024

$ 84.17M

Maximum

Dec 31, 2021

$ 30.33M

Average

$ 21.25M

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.65M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.65M
median$ 1.92M
std$ 15.86M